Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-023072

Chief Medical Officer sold 10,000 shares at an average $66.57 ($665,747)

  • Chief Medical Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bowden Christopher Chief Medical Officer 2019-04-01 Option exercise +10,000 $35.16 $351,600 17,238 D
Bowden Christopher Chief Medical Officer 2019-04-01 Sale −5,854 $66.03 $386,540 11,384 D
Bowden Christopher Chief Medical Officer 2019-04-01 Sale −2,546 $66.85 $170,200 8,838 D
Bowden Christopher Chief Medical Officer 2019-04-01 Sale −1,500 $68.09 $102,135 7,338 D
Bowden Christopher Chief Medical Officer 2019-04-01 Sale −100 $68.72 $6,872 7,238 D
Derivatives
Bowden Christopher Chief Medical Officer 2019-04-01 Option exercise · Stock option (right to buy) −10,000 71,000 D
Open-market sales · 10,000 sh · avg $66.57 · $665,747
Loading xslF345X03/doc4.xml…